Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Depreciation and Depletion: 2023-2025

Historic Depreciation and Depletion for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $798,000.

  • Immunocore Holdings' Depreciation and Depletion fell 22.90% to $798,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 11.60%. This contributed to the annual value of $4.2 million for FY2024, which is 2.79% up from last year.
  • Immunocore Holdings' Depreciation and Depletion amounted to $798,000 in Q3 2025, which was up 2.31% from $780,000 recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Depreciation and Depletion peaked at $1.2 million during Q4 2024, and registered a low of $780,000 during Q2 2025.
  • Moreover, its 3-year median value for Depreciation and Depletion was $1.0 million (2024), whereas its average is $975,091.
  • Per our database at Business Quant, Immunocore Holdings' Depreciation and Depletion grew by 12.98% in 2024 and then fell by 22.90% in 2025.
  • Quarterly analysis of 3 years shows Immunocore Holdings' Depreciation and Depletion stood at $1.0 million in 2023, then climbed by 12.98% to $1.2 million in 2024, then declined by 22.90% to $798,000 in 2025.
  • Its Depreciation and Depletion stands at $798,000 for Q3 2025, versus $780,000 for Q2 2025 and $854,000 for Q1 2025.